Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations
Closely watched data from Eli Lilly and Viking Therapeutics this month have reignited the discussion around oral weight-loss drugs—and their ultimate place within the anti-obesity medication market.Read more:
biospace.comBiotechnology